Herbal medicine in the treatment of ulcerative colitis
- PMID: 22249085
- PMCID: PMC3271691
- DOI: 10.4103/1319-3767.91726
Herbal medicine in the treatment of ulcerative colitis
Abstract
Ulcerative colitis (UC) is a refractory, chronic, and nonspecific disease occurred usually in the rectum and the entire colon. The etiopathology is probably related to dysregulation of the mucosal immune response toward the resident bacterial flora together with genetic and environmental factors. Several types of medications are used to control the inflammation or reduce symptoms. Herbal medicine includes a wide range of practices and therapies outside the realms of conventional Western medicine. However, there are limited controlled evidences indicating the efficacy of traditional Chinese medicines, such as aloe vera gel, wheat grass juice, Boswellia serrata, and bovine colostrum enemas in the treatment of UC. Although herbal medicines are not devoid of risk, they could still be safer than synthetic drugs. The potential benefits of herbal medicine could lie in their high acceptance by patients, efficacy, relative safety, and relatively low cost. Patients worldwide seem to have adopted herbal medicine in a major way, and the efficacy of herbal medicine has been tested in hundreds of clinical trials in the management of UC. The evidences on herbal medicine are incomplete, complex, and confusing, and certainly associated with both risks and benefits. There is a need for further controlled clinical trials of the potential efficacy of herbal medicine approaches in the treatment of UC, together with enhanced legislation to maximize their quality and safety.
Conflict of interest statement
Similar articles
-
Review article: complementary and alternative therapies for inflammatory bowel disease.Aliment Pharmacol Ther. 2006 Feb 1;23(3):341-9. doi: 10.1111/j.1365-2036.2006.02761.x. Aliment Pharmacol Ther. 2006. PMID: 16422993 Review.
-
A Comprehensive Review of Traditional Chinese Medicine in the Management of Ulcerative Colitis.Am J Chin Med. 2025;53(2):435-473. doi: 10.1142/S0192415X2550017X. Epub 2025 Mar 11. Am J Chin Med. 2025. PMID: 40066486 Review.
-
Advances in treatment of ulcerative colitis with herbs: from bench to bedside.World J Gastroenterol. 2014 Oct 21;20(39):14099-104. doi: 10.3748/wjg.v20.i39.14099. World J Gastroenterol. 2014. PMID: 25339799 Free PMC article. Review.
-
Contemporary overview on clinical trials and future prospects of hepato-protective herbal medicines.Rev Recent Clin Trials. 2012 Aug;7(3):214-23. doi: 10.2174/157488712802281240. Rev Recent Clin Trials. 2012. PMID: 22540904 Review.
-
Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.Trials. 2021 Jan 13;22(1):55. doi: 10.1186/s13063-020-05012-8. Trials. 2021. PMID: 33441157 Free PMC article.
Cited by
-
Angelica acutiloba Kitagawa Extract Attenuates DSS-Induced Murine Colitis.Mediators Inflamm. 2016;2016:9275083. doi: 10.1155/2016/9275083. Epub 2016 May 17. Mediators Inflamm. 2016. PMID: 27293323 Free PMC article.
-
Exploration of the Potential Mechanisms of Wumei Pill for the Treatment of Ulcerative Colitis by Network Pharmacology.Gastroenterol Res Pract. 2021 Dec 21;2021:4227668. doi: 10.1155/2021/4227668. eCollection 2021. Gastroenterol Res Pract. 2021. PMID: 34970312 Free PMC article.
-
Biochemical evaluation and molecular docking assessment of the anti-inflammatory potential of Phyllanthus nivosus leaf against ulcerative colitis.Heliyon. 2020 May 12;6(5):e03893. doi: 10.1016/j.heliyon.2020.e03893. eCollection 2020 May. Heliyon. 2020. PMID: 32426537 Free PMC article.
-
Overview of the phytomedicine approaches against Helicobacter pylori.World J Gastroenterol. 2014 May 21;20(19):5594-609. doi: 10.3748/wjg.v20.i19.5594. World J Gastroenterol. 2014. PMID: 24914319 Free PMC article. Review.
-
Helicobacter pylori: Routes of Infection, Antimicrobial Resistance, and Alternative Therapies as a Means to Develop Infection Control.Diseases. 2024 Dec 3;12(12):311. doi: 10.3390/diseases12120311. Diseases. 2024. PMID: 39727641 Free PMC article. Review.
References
-
- Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–29. - PubMed
-
- Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet. 2007;369:1627–40. - PubMed
-
- Loftus EV., Jr Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17. - PubMed
-
- Card T, Hubbard R, Logan RF. Mortality in inflammatory bowel disease: a population-based cohort study. Gastroenterology. 2003;125:1583–90. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical